Release Date: 02/04/14 09:21 Summary: Change in substantial holding from MLM Price Sensitive: No Download Document 193.83KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%